Mondrian Investment Partners LTD - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
Mondrian Investment Partners LTD ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$67,698,906
+0.9%
664,6270.0%1.39%
+4.0%
Q2 2023$67,067,511
+6.0%
664,627
-3.3%
1.34%
-3.9%
Q1 2023$63,261,684
+100725.1%
687,627
-0.6%
1.40%
+0.6%
Q4 2022$62,744
-99.9%
691,627
-7.7%
1.39%
+11.3%
Q3 2022$56,979,000
-15.5%
749,627
-6.0%
1.25%
-11.4%
Q2 2022$67,429,000
-11.3%
797,698
-8.0%
1.41%
-9.9%
Q1 2022$76,053,000
+7.8%
866,698
+7.4%
1.56%
+12.1%
Q4 2021$70,562,000
+36.2%
806,698
+27.3%
1.39%
+33.3%
Q3 2021$51,808,000
-10.4%
633,5100.0%1.05%
-5.3%
Q2 2021$57,801,000
+7.0%
633,5100.0%1.10%
-4.4%
Q1 2021$54,000,000
+27.2%
633,510
+41.0%
1.16%
+10.1%
Q4 2020$42,438,000
+19.2%
449,417
-1.5%
1.05%
-15.0%
Q3 2020$35,609,000
-10.0%
456,054
+0.7%
1.23%
-12.9%
Q2 2020$39,560,000
+6.8%
452,946
+0.8%
1.42%
+9.4%
Q1 2020$37,048,000
-22.1%
449,333
-10.6%
1.30%
+3.6%
Q4 2019$47,566,000
+9.0%
502,3330.0%1.25%
-11.2%
Q3 2019$43,653,000
-4.8%
502,3330.0%1.41%
-3.9%
Q2 2019$45,868,000
-5.0%
502,3330.0%1.46%
-3.9%
Q1 2019$48,294,000
+12.0%
502,3330.0%1.52%
-3.7%
Q4 2018$43,105,000
-8.8%
502,333
-8.4%
1.58%
+7.0%
Q3 2018$47,244,000
+14.1%
548,3330.0%1.48%
+22.3%
Q2 2018$41,421,000
-1.5%
548,3330.0%1.21%
+5.6%
Q1 2018$42,052,000
-9.7%
548,333
-1.1%
1.15%
+1.1%
Q4 2017$46,548,000
-2.2%
554,4050.0%1.13%
-6.1%
Q3 2017$47,596,000
+2.9%
554,405
-0.0%
1.21%
-8.8%
Q2 2017$46,276,000
+26.6%
554,407
+12.6%
1.32%
+28.7%
Q1 2017$36,566,000
+35.6%
492,341
+32.9%
1.03%
+32.1%
Q4 2016$26,976,000
-7.7%
370,3410.0%0.78%
+8.8%
Q3 2016$29,242,000
-4.3%
370,3410.0%0.72%
-0.8%
Q2 2016$30,557,000
+39.1%
370,341
+22.1%
0.72%
+48.0%
Q1 2016$21,972,000
-22.5%
303,308
-7.9%
0.49%
-21.7%
Q4 2015$28,334,000
-15.6%
329,312
-9.9%
0.62%
-12.5%
Q3 2015$33,585,000
-6.5%
365,3670.0%0.71%
+16.9%
Q2 2015$35,930,000
-0.2%
365,367
+0.1%
0.61%
+3.6%
Q1 2015$35,993,000
+5.8%
365,000
-0.5%
0.59%
+7.3%
Q4 2014$34,006,000
-8.1%
367,000
-6.6%
0.55%
+6.6%
Q3 2014$36,993,000
-18.6%
393,000
-21.7%
0.51%
-19.4%
Q2 2014$45,446,000
+6.5%
502,0000.0%0.64%
+1.9%
Q1 2014$42,680,000
+5.8%
502,0000.0%0.63%
+10.8%
Q4 2013$40,351,000
+4.8%
502,0000.0%0.56%
-0.5%
Q3 2013$38,508,000
+8.5%
502,0000.0%0.57%
+5.0%
Q2 2013$35,496,000502,0000.54%
Other shareholders
NOVARTIS A G shareholders Q4 2013
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders